BVF INC/IL Diversified Active

Name: BVF INC/IL Q1 2026 13F Filing | 13F Explorer
Creator: BVF INC/IL
Published: 2026-05-15

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $3.139B (100.0% shares, 0.0% debt)

Holdings (41)

New Positions (4)

ALKS ALKERMES PLC 2.3%

Value $70.72M Shares 2,000,000 Est. Cost $32.34 Unrealized 0.0%

STRO SUTRO BIOPHARMA INC 1.0%

Value $31.18M Shares 1,251,788 Est. Cost $15.08 Unrealized 0.0%

AVR ANTERIS TECHNOLOGIES GLOBAL 0.5%

Value $16.65M Shares 3,000,000 Est. Cost $5.58 Unrealized 0.0%

OKUR ONKURE THERAPEUTICS INC 0.3%

Value $8.193M Shares 1,978,972 Est. Cost $2.73 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	2,000,000	$70.72M	2.3%	$32.34	0.0%	SHS	G01767105
STRO	SUTRO BIOPHARMA INC	1,251,788	$31.18M	1.0%	$15.08	0.0%	COM SHS	869367201
AVR	ANTERIS TECHNOLOGIES GLOBAL	3,000,000	$16.65M	0.5%	$5.58	0.0%	COM	03675P102
OKUR	ONKURE THERAPEUTICS INC	1,978,972	$8.193M	0.3%	$2.73	0.0%	COM CL A	68277Q105

Increased Positions (10)

NKTR NEKTAR THERAPEUTICS 5.9%

Value $184M (+179.3%) Shares 2,559,595 (+64.1%) Est. Cost $41.58 Unrealized +16.2%

IRON DISC MEDICINE INC 2.6%

Value $81.35M (+57.6%) Shares 1,272,312 (+95.7%) Est. Cost $79.38 Unrealized -6.7%

MIRM MIRUM PHARMACEUTICALS INC 4.7%

Value $146M (+23.9%) Shares 1,584,727 (+6.0%) Est. Cost $31.29 Unrealized +208.7%

PVLA PALVELLA THERAPEUTICS INC NE 3.8%

Value $120M (+30.2%) Shares 960,989 (+9.3%) Est. Cost $32.74 Unrealized +179.1%

GLUE MONTE ROSA THERAPEUTICS INC 2.3%

Value $73.38M (+22.0%) Shares 4,460,886 (+16.3%) Est. Cost $8.74 Unrealized +136.3%

STOK STOKE THERAPEUTICS INC 2.6%

Value $82.95M (+15.3%) Shares 2,547,557 (+12.4%) Est. Cost $21.85 Unrealized +45.7%

FHTX FOGHORN THERAPEUTICS INC 0.9%

Value $27.92M (-2.5%) Shares 5,842,000 (+10.2%) Est. Cost $5.93 Unrealized -4.1%

TCRX TSCAN THERAPEUTICS INC 0.2%

Value $5.62M (+7.5%) Shares 5,564,290 (+6.5%) Est. Cost $2.33 Unrealized -54.2%

AVTX AVALO THERAPEUTICS INC 0.8%

Value $24.38M (-0.9%) Shares 1,632,845 (+20.5%) Est. Cost $10.86 Unrealized +42.6%

IMA IMAGENEBIO INC 0.2%

Value $5.55M (+0.3%) Shares 1,110,002 (+38.4%) Est. Cost $11.49 Unrealized -39.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NKTR	NEKTAR THERAPEUTICS	2,559,595 (+64.1%)	$184M (+179.3%)	5.9%	$41.58	+16.2%	COM NEW	640268306
IRON	DISC MEDICINE INC	1,272,312 (+95.7%)	$81.35M (+57.6%)	2.6%	$79.38	-6.7%	COM	254604101
MIRM	MIRUM PHARMACEUTICALS INC	1,584,727 (+6.0%)	$146M (+23.9%)	4.7%	$31.29	+208.7%	COM	604749101
PVLA	PALVELLA THERAPEUTICS INC NE	960,989 (+9.3%)	$120M (+30.2%)	3.8%	$32.74	+179.1%	COM	697947109
GLUE	MONTE ROSA THERAPEUTICS INC	4,460,886 (+16.3%)	$73.38M (+22.0%)	2.3%	$8.74	+136.3%	COM	61225M102
STOK	STOKE THERAPEUTICS INC	2,547,557 (+12.4%)	$82.95M (+15.3%)	2.6%	$21.85	+45.7%	COM	86150R107
FHTX	FOGHORN THERAPEUTICS INC	5,842,000 (+10.2%)	$27.92M (-2.5%)	0.9%	$5.93	-4.1%	COM	344174107
TCRX	TSCAN THERAPEUTICS INC	5,564,290 (+6.5%)	$5.62M (+7.5%)	0.2%	$2.33	-54.2%	COM	89854M101
AVTX	AVALO THERAPEUTICS INC	1,632,845 (+20.5%)	$24.38M (-0.9%)	0.8%	$10.86	+42.6%	COM NEW	05338F306
IMA	IMAGENEBIO INC	1,110,002 (+38.4%)	$5.55M (+0.3%)	0.2%	$11.49	-39.9%	COM	45175G207

Exited Positions (4)

ABVX ABIVAX SA 2.2%

Value $68.51M Shares 508,031 Est. Cost $84.90 Unrealized —

— REPARE THERAPEUTICS INC 0.9%

Value $26.87M Shares 10,333,600 Est. Cost $19.56 Unrealized —

PEPG PEPGEN INC 0.4%

Value $12.47M Shares 1,915,000 Est. Cost $1.61 Unrealized +261.7%

AXSM AXSOME THERAPEUTICS INC 0.3%

Value $8.357M Shares 45,757 Est. Cost $85.51 Unrealized +110.8%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ABVX	ABIVAX SA	508,031	$68.51M	2.2%	$84.90	—	—	00370M103
—	REPARE THERAPEUTICS INC	10,333,600	$26.87M	0.9%	$19.56	—	—	760273102
PEPG	PEPGEN INC	1,915,000	$12.47M	0.4%	$1.61	+261.7%	—	713317105
AXSM	AXSOME THERAPEUTICS INC	45,757	$8.357M	0.3%	$85.51	+110.8%	—	05464T104

Decreased Positions (10)

MLTX MOONLAKE IMMUNOTHERAPEUTICS 9.5%

Value $298M (+14.6%) Shares 16,001,284 (-19.0%) Est. Cost $6.29 Unrealized +155.4%

KURA KURA ONCOLOGY INC 2.2%

Value $68.66M (-23.3%) Shares 8,445,769 (-2.0%) Est. Cost $9.56 Unrealized -9.9%

TYRA TYRA BIOSCIENCES INC 2.4%

Value $75.69M (+35.3%) Shares 1,976,196 (-7.1%) Est. Cost $16.23 Unrealized +86.4%

SEPN SEPTERNA INC 1.0%

Value $32.52M (-32.2%) Shares 1,353,249 (-21.4%) Est. Cost $18.24 Unrealized +45.4%

IMCR IMMUNOCORE HLDGS PLC 1.2%

Value $39.03M (-22.4%) Shares 1,294,463 (-13.1%) Est. Cost $33.11 Unrealized —

RVMD REVOLUTION MEDICINES INC 8.9%

Value $278M (+3.9%) Shares 2,856,782 (-14.9%) Est. Cost $31.23 Unrealized +229.8%

ZYME ZYMEWORKS INC 3.0%

Value $93.5M (-9.8%) Shares 3,734,142 (-5.2%) Est. Cost $7.03 Unrealized +232.6%

GHRS GH RESEARCH PLC 3.9%

Value $122M (+8.5%) Shares 8,650,158 (-2.0%) Est. Cost $18.98 Unrealized -17.2%

FDMT 4D MOLECULAR THERAPEUTICS IN 0.9%

Value $26.81M (-22.8%) Shares 2,879,289 (-37.8%) Est. Cost $13.79 Unrealized -37.9%

ANNX ANNEXON INC 1.5%

Value $48.19M (+5.2%) Shares 8,698,173 (-4.7%) Est. Cost $2.79 Unrealized +106.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	16,001,284 (-19.0%)	$298M (+14.6%)	9.5%	$6.29	+155.4%	CLASS A ORD	61559X104
KURA	KURA ONCOLOGY INC	8,445,769 (-2.0%)	$68.66M (-23.3%)	2.2%	$9.56	-9.9%	COM	50127T109
TYRA	TYRA BIOSCIENCES INC	1,976,196 (-7.1%)	$75.69M (+35.3%)	2.4%	$16.23	+86.4%	COM	90240B106
SEPN	SEPTERNA INC	1,353,249 (-21.4%)	$32.52M (-32.2%)	1.0%	$18.24	+45.4%	COM	81734D104
IMCR	IMMUNOCORE HLDGS PLC	1,294,463 (-13.1%)	$39.03M (-22.4%)	1.2%	$33.11	—	ADS	45258D105
RVMD	REVOLUTION MEDICINES INC	2,856,782 (-14.9%)	$278M (+3.9%)	8.9%	$31.23	+229.8%	COM	76155X100
ZYME	ZYMEWORKS INC	3,734,142 (-5.2%)	$93.5M (-9.8%)	3.0%	$7.03	+232.6%	COM	98985Y108
GHRS	GH RESEARCH PLC	8,650,158 (-2.0%)	$122M (+8.5%)	3.9%	$18.98	-17.2%	ORDINARY SHARES	G3855L106
FDMT	4D MOLECULAR THERAPEUTICS IN	2,879,289 (-37.8%)	$26.81M (-22.8%)	0.9%	$13.79	-37.9%	COM	35104E100
ANNX	ANNEXON INC	8,698,173 (-4.7%)	$48.19M (+5.2%)	1.5%	$2.79	+106.0%	COM	03589W102

Unchanged Positions (17)

GPCR STRUCTURE THERAPEUTICS INC 5.3%

Value $167M Shares 3,459,358 Est. Cost $34.45 Unrealized —

OLMA OLEMA PHARMACEUTICALS INC 2.5%

Value $78.96M Shares 5,295,893 Est. Cost $37.66 Unrealized -32.4%

KYMR KYMERA THERAPEUTICS INC 14.6%

Value $458M Shares 5,502,710 Est. Cost $32.29 Unrealized +140.3%

XNCR XENCOR INC 2.7%

Value $86.03M Shares 7,133,720 Est. Cost $17.12 Unrealized -26.1%

IVVD INVIVYD INC 0.8%

Value $25.38M Shares 19,525,000 Est. Cost $2.08 Unrealized -4.9%

CGEM CULLINAN THERAPEUTICS INC 2.6%

Value $81.72M Shares 5,750,683 Est. Cost $20.31 Unrealized -41.1%

CBIO CRESCENT BIOPHARMA INC. 1.6%

Value $50.49M Shares 2,748,763 Est. Cost $16.98 Unrealized -34.9%

XOMA XOMA ROYALTY CORPORATION 2.6%

Value $81.26M Shares 2,590,303 Est. Cost $15.57 Unrealized +67.7%

ELDN ELEDON PHARMACEUTICALS INC 0.6%

Value $19.38M Shares 6,293,282 Est. Cost $4.95 Unrealized -57.9%

ACIU AC IMMUNE SA 1.7%

Value $54.51M Shares 19,822,436 Est. Cost $4.49 Unrealized -28.1%

IMUX IMMUNIC INC 0.3%

Value $8.495M Shares 7,652,972 Est. Cost $1.30 Unrealized -44.5%

TENX TENAX THERAPEUTICS INC 0.2%

Value $5.429M Shares 339,549 Est. Cost $3.62 Unrealized +272.6%

CMPX COMPASS THERAPEUTICS INC 1.3%

Value $41.08M Shares 7,764,842 Est. Cost $3.73 Unrealized +61.1%

IVA INVENTIVA SA 0.1%

Value $3.808M Shares 686,040 Est. Cost $13.70 Unrealized —

MOLN MOLECULAR PARTNERS AG 0.2%

Value $5.362M Shares 1,353,968 Est. Cost $9.66 Unrealized —

XFOR X4 PHARMACEUTICALS INC 0.3%

Value $9.225M Shares 2,233,742 Est. Cost $2.58 Unrealized +41.0%

ENGNW ENGENE HOLDINGS INC 0.1%

Value $2.486M Shares 945,402 Est. Cost $0.85 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GPCR	STRUCTURE THERAPEUTICS INC	3,459,358	$167M	5.3%	$34.45	—	SPONSORED ADS	86366E106
OLMA	OLEMA PHARMACEUTICALS INC	5,295,893	$78.96M	2.5%	$37.66	-32.4%	COM	68062P106
KYMR	KYMERA THERAPEUTICS INC	5,502,710	$458M	14.6%	$32.29	+140.3%	COM	501575104
XNCR	XENCOR INC	7,133,720	$86.03M	2.7%	$17.12	-26.1%	COM	98401F105
IVVD	INVIVYD INC	19,525,000	$25.38M	0.8%	$2.08	-4.9%	COM	00534A102
CGEM	CULLINAN THERAPEUTICS INC	5,750,683	$81.72M	2.6%	$20.31	-41.1%	COM	230031106
CBIO	CRESCENT BIOPHARMA INC.	2,748,763	$50.49M	1.6%	$16.98	-34.9%	COM	G2545C104
XOMA	XOMA ROYALTY CORPORATION	2,590,303	$81.26M	2.6%	$15.57	+67.7%	COM NEW	98419J206
ELDN	ELEDON PHARMACEUTICALS INC	6,293,282	$19.38M	0.6%	$4.95	-57.9%	COM	28617K101
ACIU	AC IMMUNE SA	19,822,436	$54.51M	1.7%	$4.49	-28.1%	SHS	H00263105
IMUX	IMMUNIC INC	7,652,972	$8.495M	0.3%	$1.30	-44.5%	COM	4525EP101
TENX	TENAX THERAPEUTICS INC	339,549	$5.429M	0.2%	$3.62	+272.6%	COM NEW	88032L605
CMPX	COMPASS THERAPEUTICS INC	7,764,842	$41.08M	1.3%	$3.73	+61.1%	COM	20454B104
IVA	INVENTIVA SA	686,040	$3.808M	0.1%	$13.70	—	ADS	46124U107
MOLN	MOLECULAR PARTNERS AG	1,353,968	$5.362M	0.2%	$9.66	—	ADS	60853G106
XFOR	X4 PHARMACEUTICALS INC	2,233,742	$9.225M	0.3%	$2.58	+41.0%	COM NEW	98420X202
ENGNW	ENGENE HOLDINGS INC	945,402	$2.486M	0.1%	$0.85	—	*W EXP 10/31/202	29286M113